Synthetic THC And Blood Pressure
ConditionBlood Pressure
Trial statusNot yet recruiting
Trial phasePhase 2, Phase 3
Trial typeInterventional
Biological sexAll
Age21-40
SponsorMayo Clinic
About this trial
To investigate the effects of Dronabinol use on blood pressure and neurovascular physiology
Eligibility criteria
Qualifiers
Recreational occasional Cannabis use (Consuming THC less than 2 times a week)
21 - 40 years of age
Biological male or female
Disqualifiers
BMI > 35 kg/m2
Diagnosed psychiatric disorders
Hypotension
History of seizures
Trial design
Treatments tested in this trial
- Dronabinol
- Placebo
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov